Euro area vs Tonga: Cause of death, by non-communicable diseases, ages 60+
Euro area
82.0%
in 2021
Tonga
89.9%
in 2021
Euro area rank
5th
Tonga rank
8th
Cause of death, by non-communicable diseases, ages 60+ over time
- Euro area
- Tonga
How they compare
Tonga currently reports 89.9% against 82.0% in Euro area, a difference of 7.9%.
That makes Tonga's figure about 1.1 times Euro area's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Euro area ahead.
Euro area ranks 5th and Tonga ranks 8th of 47 groups.
Across the 3 decades both report, Euro area averaged higher in 2 and Tonga in 1.
Head to head by decade
| Decade | Euro area | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 89.4% | 2.9% | Euro area |
| 2010s | 91.3% | 89.9% | 1.4% | Euro area |
| 2020s | 82.1% | 90.0% | 7.9% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Euro area or Tonga?
- Tonga, at 89.9% against 82.0% in Euro area as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Euro area and Tonga?
- 7.9%, with Tonga ahead.
- How many years of comparable data are there for Euro area and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Euro area and Tonga rank globally for cause of death, by non-communicable diseases, ages 60+?
- Euro area ranks 5th and Tonga ranks 8th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.